It is a Herculean effort to develop a novel vaccine on an unprecedented timeline. Experts discuss the latest research regarding the development of vaccine candidates for the COVID-19 virus and some of the issues that will need to be addressed when a successful candidate has been identified, including clinical trial enrollment, manufacturing, and distribution.
Watch Video
Watch Video
By Sibel Blau, MD; Bruce Feinberg, DO; William Mitchell, MD; Amy Valley, PharmD; Burt Zweigenhaft, PhD, D.Litt
Community oncology practices say they are recovering from the COVID-19 pandemic and keeping their eye on the goal of value-based care. The strategies they are using to accomplish these initiatives include innovation, long-term integration of telehealth, and the leveraging of advanced practice professionals.
Watch Video
Watch Video
By Andrea Dwyer, BS; Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN; Brenda Nevidjon, MSN, RN, FAAN; Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG; Burt Zweigenhaft, PhD, D.Litt
The COVID-19 pandemic has created significant barriers to care, which can lead to increased mortality rates for thousands of patients with cancer. Nurses and nurse navigators are focused on using their skills and experience to combat this trend. Ongoing efforts include educating patients on the importance of undergoing cancer screenings, utilizing telehealth services to enhance communication with patients, addressing staffing shortages, and taking the necessary steps for preparing for potential spikes in COVID-19 cases.
Watch Video
Watch Video
Although several of the financial indicators in oncology have recovered to pre-pandemic levels following dramatic declines that occurred earlier in the year, there are still significant challenges ahead. How will providers manage the backlog? What will happen to patients’ insurance coverage? How will oncology practices survive and thrive in a post–COVID-19 world?
Watch Video
Watch Video
By Naomi Gutierrez; Lisa Harrison, RPh; Duane Kembel; Patrick Schmidt; Burt Zweigenhaft, PhD, D.Litt
From the management of extended payment terms and performance-based agreements, to the potential impact of the proposed 2021 Medicare rules and the impending shortages of immune globulin, wholesale suppliers discuss how the COVID-19 pandemic continues to affect the oncology supply chain, what is being done to help practices, and what challenges lie ahead.
Watch Video
Watch Video
By Bob Gold; Rick Lee; Brian Leyland-Jones, MD; Debra Patt, MD, PhD, MBA; Chevon Rariy, MD; Burt Zweigenhaft, PhD, D.Litt
Can the use of telehealth services help to address the upcoming burden of late cancer diagnoses, improve the co-management of chronic conditions, and give patients more power over their own health? During a recent AVBCC webinar, a panel of experts explored this question as they discussed the potential role of wearables, remote monitoring and communication, and other innovative technology for improving care for patients with cancer.
Watch Video
Watch Video
By Rob Butcher; John de Groot, MD; Adam Gadzinski, MD, MS; Robyn Gartrell, MD, MS; Denise McDade; Burt Zweigenhaft, PhD, D.Litt
With many clinical trials on hold and COVID-19 studies the only new trials opening up, how are cancer researchers adapting to the new environment? Can lessons from COVID-19 facilitate improved clinical trial recruitment and retention in the future?
Watch Video
Watch Video
By Deborah Kamin, RN, PhD; Ted Okon, MBA; John O’Brien, PharmD, MPH; Jayson Slotnik, JD, MPH; Burt Zweigenhaft, PhD, D.Litt
Telehealth reimbursement. 340B. Drug pricing negotiations. There’s been a lot of action on healthcare-related proposals in Washington in recent weeks. What’s likely to last, and what is just “political theater”? AVBCC’s panel of experts has the inside scoop.
Watch Video
Watch Video
With the chaos in the workplace and in healthcare caused by the COVID-19 pandemic, experts predict that most major employers will not be looking to add any more disruption with significant changes to their benefit plans for 2021.
Watch Video
Watch Video
By Marianne Gandee; Gerry Gleeson, MBA; Rena Goins; Arthur Hirt; Alan Tubbs; Burt Zweigenhaft, PhD, D.Litt
Initiatives to expand patient access programs, strategies to secure the supply chain, and updates on vaccine trials: leaders from top pharmaceutical manufacturers discussed their companies’ ongoing response to the worldwide pandemic in this AVBCC webcast.
Watch Video
Watch Video